Cargando…

Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients

Allogeneic stem cell transplantation (alloSCT) is utilised to cure haematological malignancies through a combination of conditioning regimen intensity and immunological disease control via the graft versus tumour (GVT) effect. Currently, conventional myeloablative chemotherapeutic or chemoradiation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Joanne E., Du, Kelei, Ludford-Menting, Mandy J., Prabahran, Ashvind, Wong, Eric, Huntington, Nicholas D., Koldej, Rachel M., Ritchie, David S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498041/ https://www.ncbi.nlm.nih.gov/pubmed/34630428 http://dx.doi.org/10.3389/fimmu.2021.749094

Ejemplares similares

Clinical features, pathophysiology, and therapy of poor graft function post–allogeneic stem cell transplantation
por: Prabahran, Ashvind, et al.
Publicado: (2022)

Spatial proteomics identifies a spectrum of immune dysregulation in acquired bone marrow failure syndromes
por: Koldej, Rachel M., et al.
Publicado: (2023)

Dissection of the bone marrow microenvironment in hairy cell leukaemia identifies prognostic tumour and immune related biomarkers
por: Koldej, Rachel M., et al.
Publicado: (2021)

A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma
por: Jake Shortt, et al.
Publicado: (2023)

Association between P2X7 Polymorphisms and Post-Transplant Outcomes in Allogeneic Haematopoietic Stem Cell Transplantation
por: Koldej, Rachel M, et al.
Publicado: (2020)

Kinetics of neutrophil engraftment in allogeneic stem cell transplantation
por: Kawajiri, Akihisa, et al.
Publicado: (2019)

Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
por: Gaffney, Kelly J., et al.
Publicado: (2023)

P799: SPATIAL ANALYSIS IDENTIFIES A SPECTRUM OF IMMUNE DYSREGULATION IN ACQUIRED BONE MARROW FAILURE CONDITIONS
por: Koldej, R., et al.
Publicado: (2022)

Plasma Cell Leukemia with Successful Upfront Venetoclax in Combination with Allogeneic Transplantation
por: Tang, Andy Sing Ong, et al.
Publicado: (2023)

Allogeneic Hair Transplant in a Kidney Transplant Recipient
por: Popescu, Felix Mircea, et al.
Publicado: (2023)

Second Allogeneic Hematopoietic Stem Cell Transplantation for Hemophagocytic Syndrome with Engraftment Failure
por: Jiang, Fan, et al.
Publicado: (2022)

Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase
por: Oltolini, Chiara, et al.
Publicado: (2020)

An Unusual Presentation of Nocardiosis in an Allogeneic Transplant Recipient
por: Ibrahim, Uroosa, et al.
Publicado: (2016)

Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients
por: Hatfield, Kimberley Joanne, et al.
Publicado: (2022)

Relevant proteins for the monitoring of engraftment phases after allogeneic hematopoietic stem cell transplantation
por: Souza, Milena Monteiro, et al.
Publicado: (2022)

Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups
por: Robin, Marie, et al.
Publicado: (2021)

Does Total Body Irradiation Have a Favorable Impact on Thrombocyte Engraftment as per Neutrophil Engraftment in Allogeneic Stem Cell Transplantation?
por: Uncu Ulu, Bahar, et al.
Publicado: (2021)

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
por: Joshi, Maansi, et al.
Publicado: (2021)

Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib
por: Foss, Francine M., et al.
Publicado: (2020)

Correction Notice: Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threatening Features Within the Early Post-engraftment Phase
Publicado: (2020)

Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation Recipients
por: Chen, Weihao, et al.
Publicado: (2022)

Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant
por: Rahmat, Leena T., et al.
Publicado: (2018)

Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
por: Cao, Xing-yu, et al.
Publicado: (2023)

Recurrent Subcutaneous Sweet's Disease in a Myelofibrosis Patient Treated with Ruxolitinib before Allogeneic Stem Cell Transplantation
por: Sakoda, Teppei, et al.
Publicado: (2017)

Post-engraftment Bloodstream Infections After Allogeneic Hematopoietic Cell Transplantation: Risk Factors and Association with Mortality
por: Akhmedov, Mobil, et al.
Publicado: (2023)

Donor bone marrow–derived macrophage engraftment into the central nervous system of patients following allogeneic transplantion
por: Loeb, Anisha M., et al.
Publicado: (2023)

Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes
por: Jungius, Sarah, et al.
Publicado: (2023)

Cytomegalovirus monitoring in allogeneic haemopoietic stem cell transplant recipients
por: Ramalingam, S., et al.
Publicado: (2006)

Scabies crustosa in a recipient of an allogeneic stem cell transplantation
por: Christopeit, Maximilian, et al.
Publicado: (2020)

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
por: Kum, Elena, et al.
Publicado: (2021)

Cutaneous Legionella infections in allogeneic hematopoietic cell transplantation recipients
por: Vaidya, Toral, et al.
Publicado: (2020)

Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant
por: McEwan, Ashley, et al.
Publicado: (2020)

Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia
por: Hassan, Mona Ali, et al.
Publicado: (2023)

Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Hengwei, et al.
Publicado: (2021)

P1308: RUXOLITINIB AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA PATIENTS
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review
por: Pession, Andrea, et al.
Publicado: (2021)

Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments
por: Pahl, Antonia, et al.
Publicado: (2021)

Improvement of hepatocyte engraftment by co‐transplantation with pancreatic islets in hepatocyte transplantation
por: Saitoh, Yoshikatsu, et al.
Publicado: (2021)

Levofloxacin Versus Ciprofloxacin-Based Prophylaxis during the Pre-Engraftment Phase in Allogeneic Hematopoietic Stem Cell Transplant Pediatric Recipients: A Single-Center Retrospective Matched Analysis
por: Servidio, Alessia G., et al.
Publicado: (2021)

Toxoplasma Encephalitis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient in Korea
por: Park, Soo-Kyung, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tj23hc3ojteknjkjf1qptqel1i